How many 8-K filings has Co-Diagnostics, Inc. filed?

Co-Diagnostics, Inc. (CODX) has 14 8-K (Current Event Report) filings on record, spanning Mar 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Co-Diagnostics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Co-Diagnostics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Co-Diagnostics, Inc. (CODX) — 8-K Filings

All 8-K filings from Co-Diagnostics, Inc.. Browse 14 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (14)

8-K Filing — Dec 30, 2025
Co-Diagnostics Files 8-K on Security Holder Vote Matters — Dec 5, 2025 Risk: low
Co-Diagnostics, Inc. filed an 8-K on December 5, 2025, reporting on the submission of matters to a vote of security holders. The filing details administrative i
Co-Diagnostics, Inc. Files 8-K for Material Agreement — Oct 29, 2025 Risk: medium
On October 28, 2025, Co-Diagnostics, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements an
Co-Diagnostics Enters and Terminates Material Agreements — Oct 20, 2025 Risk: medium
Co-Diagnostics, Inc. reported on September 30, 2025, that it entered into a material definitive agreement and also terminated a material definitive agreement. T
Co-Diagnostics, Inc. Files 8-K on Sept 30, 2025 — Sep 30, 2025 Risk: low
Co-Diagnostics, Inc. filed an 8-K on September 30, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclos
Co-Diagnostics Enters Material Definitive Agreement — Sep 18, 2025 Risk: medium
Co-Diagnostics, Inc. announced on September 17, 2025, that it has entered into a material definitive agreement. The filing also indicates other events and the i
Co-Diagnostics Appoints New Chief Medical Officer — Jul 11, 2025 Risk: medium
On July 10, 2025, Co-Diagnostics, Inc. announced the appointment of Dr. Mark R. Mitchell as Chief Medical Officer. Dr. Mitchell brings extensive experience in m
Co-Diagnostics, Inc. Files 8-K on Shareholder Votes — May 29, 2025 Risk: low
Co-Diagnostics, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of security holders as of May 28, 2025. The filing details the compa
Co-Diagnostics Enters Material Definitive Agreement — Apr 28, 2025 Risk: medium
Co-Diagnostics, Inc. announced on April 25, 2025, that it has entered into a material definitive agreement. The company, incorporated in Utah with its principal
Co-Diagnostics Files 8-K: Corporate Details Updated — Feb 21, 2025 Risk: low
Co-Diagnostics, Inc. filed an 8-K on February 21, 2025, reporting other events and financial statements. The filing details the company's principal executive of
Co-Diagnostics Faces Delisting Notice — Jan 10, 2025 Risk: high
Co-Diagnostics, Inc. filed an 8-K on January 10, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, incorporated
Co-Diagnostics Reports Shareholder Vote Matters — Aug 30, 2024 Risk: low
Co-Diagnostics, Inc. filed an 8-K on August 30, 2024, reporting on matters submitted to a vote of security holders as of August 29, 2024. The filing details cor
Co-Diagnostics Files 8-K — Jun 14, 2024 Risk: low
Co-Diagnostics, Inc. filed an 8-K on June 14, 2024, reporting other events and financial statements. The filing details the company's corporate information, inc
Co-Diagnostics Appoints New CMO, Director — Mar 15, 2024 Risk: medium
Co-Diagnostics, Inc. announced on March 15, 2024, the appointment of Dr. Richard K. Smith as Chief Medical Officer and the election of Ms. Sarah J. Smith to its

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX